Abstract: Objective To improve the non-surgical N staging system for esophageal carcinoma (EC). Methods A retrospective analysis was performed in 501 patients newly diagnosed with esophageal squamous cell carcinoma who received radiotherapy in our hospital from 2009 to 2013. The impacts of the supraclavicular lymph nodes and mediastinal lymph nodes on the overall survival (OS) rate were analyzed. The original non-surgical N staging system was improved and the proposed N staging system was evaluated. The OS rates were calculated using the Kaplan-Meier method and analyzed using the log-rank test. The univariate and multivariate analyses were performed using the log-rank test and Cox regression model, respectively. Results The 3-and 5-year sample sizes were 404 and 205, respectively. In all patients, the 1-, 3-, and 5-year OS rates were 64.9%, 26.5%, and 18.3%, respectively;the 1-, 3-, and 5-year distant metastasis-free (DMF) rates were 86.2%, 68.9%, and 67.3%, respectively;the 1-, 3-, and 5-year local control rates were 72.7%, 53.1%, and 43.6%, respectively. The univariate analysis showed that the incidence, 3-year OS rate, and 3-year DMF rate of supraclavicular lymph node metastases in patients with cervical and upper-thoracic EC were significantly higher than those in patients with middle-thoracic and lower-thoracic EC (25.7% vs. 14.2%, P=0.034;24.2% vs. 11.5%, P=0.016;84.8% vs. 69.2%, P=0.007). The multivariate analysis also showed that the number of metastatic lymph nodes was anindependent prognostic factor for the OS and DMF rates in patients (P=0.000;P=0.007). ConclusionsIt is reasonable to classify upper-thoracic EC with supraclavicular lymph node metastasis into stage N1 diseases. The proposed N staging system with the factor of the number of metastatic lymph nodes is more scientific and objective than the original N staging system.
Xu Hongyao,Li Yixuan,Wu Shengxi et al. A computed tomography-based study of the non-surgical N staging system for esophageal carcinoma[J]. Chinese Journal of Radiation Oncology, 2016, 25(10): 1066-1069.
[1] Edge SB,Byrd DR,Compton CC,et al. AJCC cancer staging manual[M].7th ed. New York:Springe,2010. [2] 中国非手术治疗食管癌临床分期专家小组.非手术治疗食管癌的临床分期标准(草案)[J].中华放射肿瘤学杂志,2010,19(3):179-180.DOI:10.3760/cma.j.issn.1004-4221.2010.03.001.China non operative treatment of esophageal cancer clinical staging expert group. Standard for clinical staging of non operative treatment for esophageal cancer (Draft)[J].Chin J Radiat Oncol,2010,19(3):179-180.DOI:10.3760/cma.j.issn.1004-4221.2010.03.001. [3] Groome PA,Schulze K,Boysen M,et al. A comparison of published head and neck stage groupings in carcinomas of the oral cavity[J].Head Neck,2001,23(8):613-624.DOI:10.1002/hed.1087. [4] 乔雪,朱雅群,田野.食管癌临床分期与病理分期分布合理性和预后判断价值比较[J].中华放射肿瘤学杂志,2014,23(4):307-311.DOI:10.3760/cma.j.issn.1004-4221.2014.04.009. Qiao X,Zhu YQ,Tian Y.Comparison of rationality and prognostic value between clinical staging and pathological staging for esophageal cancer[J].Chin J Radiat Oncol,2014,23(4):307-311.DOI:10.3760/cma.j.issn.1004-4221.2014.04.009. [5] 陈建洲,陈创珍,李德锐,等.非手术治疗食管癌临床分期的验证[J].中国肿瘤,2012,21(5):374-378. Chen JZ,Chen CZ,Li DR,et al. Verification of non-surgical clinical staging for esophageal carcinoma[J].China Cancer,2012,215(5):374-378. [6] 王澜,孔洁,韩春,等.非手术治疗食管癌临床分期标准的临床应用与探讨[J].中华放射肿瘤学杂志,2012,21(4):330-333.DOI:10.3760/cma.j.issn.1004-4221.2012.04.012. Wang L,Kong J,Han C,et al. The evaluation of prognosis and investigation of clinical staging for esophageal carcinoma treated with non-surgical methods[J].Chin J Radiat Oncol,2012,21(4):330-333.DOI:10.3760/cma.j.issn.1004-4221.2012.04.012. [7] Gertler R,Schuster T,Feith M.Long-term outcome of almost 3,000 patients with carcinoma of the esophagus:evaluation of the new UICC/AJCC staging system[J].J Clin Oncol,2011,29(4 Suppl):64.